Article Sidebar

Major General, Prof. Dr. Hoang Van Luong, Deputy Director of the Military Medical University and the Hospital's Board of Directors cut the ribbon to launch the telehealth system of the project of remote medical examination and treatment project for the period of 2020-2025, on December 24, 2021.
Full article
Date Published: 26/01/2022
Online Published: 26/01/2022
Abstract Views: 279
Views Full article: 91
DOI: https://doi.org/10.54804/yhthvb.6.2021.91
Issue
No. 6 (2021)
Section
Articles
How to Cite
Phan, Q. K., Nguyen, H. A., & Nguyen, N. L. (2022). Influences of Propranolol on outcomes of severely adult burn patients. Journal of Disaster Medicine and Burn Injuries, 6, 34-40. https://doi.org/10.54804/yhthvb.6.2021.91

Influences of Propranolol on outcomes of severely adult burn patients.

Phan Quoc Khanh1, Nguyen Hai An2, Nguyen Nhu Lam3,
1 Military Medical Hospital 4/Military Region 4
2 Le Huu Trac National Burn Hospital
3 2Le Huu Trac National Burn Hospital

Main Article Content

Abstract

This study evaluated the influence of Propranolol on outcomes of severely adult burn patients. A randomized controlled trial was on 124 patients who were divided into two groups: Control group (A) received conventional treatment, study group (B) was treated with Propranolol.
The result indicated that, along the time, the heart rate of the study group steadily decreased and was significantly lower than that of the control group (90.24 ± 11.51 vs. 101.43 ± 13.69 bpm; p < 0,01 at 28th-day afterburn). From the 7th day onward afterburn, the body temperature of both groups decreased and the temperature was significantly lower than that in the control group (p < 0.05). Hematological parameters, mean arterial pressure, complication rate and treatment time were not remarkably different between the two groups (p > 0.05). There was also no significant difference in mortality between groups (19.35% vs 17.74%; p > 0.05).

Article Details

Keywords

Propranolol, severe burn, adult, outcomes

References

1. Jeschke MG, Norbury WB, Finnerty CC, et al. Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children. J Trauma 2007; 62(3):676-681.
2. Oberbeck R. Therapeutic implications of immune-endocrine interactions in the critically ill patients. Curr Drug Targets Immune Endocr Metabol Disord 2004; 4:129-139.
3. Oberbeck R, Schmitz D, Wilsenack K, et al. Adrenergic modulation of survival and cellular immune functions during polymicrobial sepsis. Neuroimmunomodulation 2004; 11:214-223.
4. Herndon DN, Rodriguez NA, Diaz EC, et al. Long-term propranolol use in severely burned pediatric patients: a randomized controlled study. Annals of surgery 2012; 256(3):402-411.
5. Williams FN, Herndon DN, Kulp GA, et al. Propranolol decreases cardiac work in a dose-dependent manner in severely burned children. Surgery 2011; 149(2):231-239.
6. Lunawat A, Vishwani A, Datey S, et al. Modulation of hypermetabolism in burn patient by administration of propranolol in the first two weeks and assessing its effect by using clinical and biochemical parameters. Indian Journal of Burns 2015; 23(1):19-25.
7. Kobayashi M, Jeschke MG, Asai A, et al. Propranolol as a modulator of M2b monocytes in severely burned patients. Journal of leukocyte biology 2011; 89(5):797-803.